molnupiravir

Study Finds Paxlovid, Molnupiravir Reduce Omicron Hospitalization, Mortality

1148d BY Aldgra Fredly
Merck’s COVID-19 Antiviral Drug Doesn’t Reduce Hospitalization or Death in High-Risk Vaccinated People: Study

1418d BY Katabella Roberts
Hong Kong Study of Oral Antivirals Shows Promise for Omicron Patients

1493d BY Liane Lau
Merck Sees 2022 Sales up Nearly 20 Percent, Mostly on New COVID Pill

1743d BY Reuters
Merck Expects COVID-19 Pill Molnupiravir to Be Effective Against Omicron

1766d BY Reuters
Merck Authorizes Indian Pharma Company to Manufacture and Supply Affordable COVID-19 Pills

1773d BY Naveen Athrappully
India Boosts Arsenal Against COVID-19 With Merck Pill, 2 More Vaccines

1780d BY Reuters
France Cancels Order for Merck’s COVID-19 Antiviral Drug

1785d BY Reuters
FDA Advisers Vote to Recommend Merck COVID-19 Pill for Emergency Use Authorization

1808d BY Mimi Nguyen Ly
WHO Says Seeks More Data From Merck on COVID-19 Anti-Viral, From Bharat on Vaccine

1841d BY Reuters
Merck Asks EU Regulator to Authorize Pill That Treats COVID-19

1844d BY The Associated Press